2019 American Transplant Congress

June 1-5, 2019 in Boston, MA

View by Title View Sessions

View by Date

Monday, June 3, 2019

4:30pm-4:42pm: A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 is Safe and Immunogenic in Healthy Volunteers and Entering a Phase 2 Trial in Kidney Transplant Recipients

C. N. Kotton¹, M. Schwendinger², G. Thiry³, B. De Vos⁴, F. De Boever⁵, G. Leroux-Roels⁶, A. Lilja⁷

Concurrent Session: Breakthroughs in Cytomegalovirus • Ballroom A

4:30pm-4:42pm: A Prospective Randomized Multicenter Trial (B E S T Trial) of Belatacept-Based C N I- and Corticosteroid-Free Immunosuppression: Final Two Year Results

D. B. Kaufman¹, A. R. Shields², J. P. Leone³, A. Wiseman⁴, A. J. Matas⁵, P. West-Thielke⁶, J. Lipscomb², E. King², R. R. Alloway⁷, E. S. Woodle for the BEST Study Group²

Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization II • Veterans Auditorium

4:30pm-4:42pm: B Cell IL-4 Signaling Induces the IL-10 Secreting TIM-1+ Bregs and Suppresses T Cell Inflammatory Cytokines

Z. Song, K. Mohib, D. M. Rothstein

Concurrent Session: Tolerance / Immune Deviation • Room 310

4:30pm-4:42pm: Capitalizing On Donor Density To Increase Organ Pool – An Analysis Of Urban And Rural Organ Donors

S. Bakhtiyar, S. Ahmed, J. A. Goss, A. Rana

Concurrent Session: Non-Organ Specific: Public Policy & Allocation • Room 311

4:30pm-4:42pm: Clazakizumab as an Agent to Reduce Donor Specific HLA Antibodies and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation

S. C. Jordan¹, N. Ammerman¹, M. Toyoda², E. Huang¹, C. C. Nast³, A. Peng¹, S. Sethi¹, R. Najjar¹, I. Kim¹, K. Lim¹, J. Choi¹, A. Vo¹

Concurrent Session: Kidney Chronic Antibody Mediated Rejection • Ballroom B

4:30pm-4:42pm: High Numbers of Differentiated CD8⁺CD28^– T Cells Are Associated with a Substantially Lowered Risk for Late Rejection and Graft Loss after Kidney Transplantation

M. G. Betjes, A. Langerak, M. Klepper, N. Litjens

Concurrent Session: Biomarkers, Immune Monitoring and Outcomes III • Room 306

4:30pm-4:42pm: Incidence of Autoresuscitation in Donation after Cardiac Death Donors

C. W. Koo¹, R. A. Helmick¹, K. Van Frank², K. Gilley², J. D. Eason¹

Concurrent Session: Donor Management: All Organs Excluding Kidney • Room 313

4:30pm-4:42pm: Increase in 48 Month Cumulative Acute Rejection Rates in the Most Recent Cohort: The 2018 Transplant Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

V. Dharnidharka¹, C. Cramer², A. Chua³, A. Moudgil⁴, K. Martz⁵, T. Blydt-Hansen⁶, J. Smith⁷, A. Neu, on Behalf of The NAPRTCS Investigators⁸

Concurrent Session: Kidney: Pediatrics II • Room 304

4:30pm-4:42pm: Not All Poor Metabolizers Are Clinically Equal: Evaluating Weight-Based Tacrolimus Outcomes in CYP3A Loss of Function Variants

A. Q. Maldonado, W. Irish, T. E. Asempa, J. Gooden, M. L. Davis, C. Haisch, H. Jones, D. Leeser, L. Rebellato

Concurrent Session: Non-Organ Specific: Pharmacogenomics / Pharmacokinetics • Room 210

4:30pm-4:42pm: Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis

K. P. Croome, D. Lee, S. Croome, R. Chadha, D. Livingston, P. Abader, A. P. Keaveny, C. Taner

Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) II • Room 302